1 suspended, 1 unknown. 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Suspended 1 |
| Phase 3 | 1 | Suspended 1 |
| Phase 4 | 1 | Unknown 1 |
Follow H.A.C. PHARMA: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hemodynamics Effects of Fludrocortisone on the Pressor Response to Noradrenaline Septic Shock Patients Fludrocortisone, Placebo - Septic Shock | Phase 2 / Phase 3 | Suspended | Rennes University Hospital | 40 | 2022-03-31 | 2023-11-18 |
| Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension Fludrocortisone, Placebo - Neurogenic Orthostatic Hypotension | Phase 4 | Unknown | H.A.C. PHARMA | 90 | 2020-07-09 | 2023-10-02 |
Shock, Septic (1)
Fludrocortisone (2)
France (2)
Bruno Laviolle, MD, PhD (1) · Harmonie Perrichet, MD (1)
2018 (1)